We anticipate IRBco’s IRB registration number with OHRP/FDA will be deactivated sometime in May. At that time, Advarra will release a 1572 Note to File regarding the transfer of studies from IRBco’s IRB to Advarra. Clients should file the Note to File alongside their IAAs; no other assignment is required. We recommend that clients with global reliance agreements or IAAs work with Advarra’s Institutions Team to enter into the global agreement under Advarra to ensure a smooth transition of services. Once the IRB registration update is complete, clients will notice that approval documents and other templates will be under the Advarra name. Until that point, all documents will continue with the entity to whom they were submitted.